NEW YORK (GenomeWeb) – The Jackson Laboratory announced last week that it has won a $1.4 million grant from the US Department of Defense (DoD) to develop a new method for classifying triple-negative breast cancer (TNBC) tumors, which could lead to the development of better diagnostics and precision treatments.